• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Exploiting the Natriuretic Peptide Pathway to Preserve Glomerular Filtration in Heart Failure.

作者信息

Mullens Wilfried, Martens Pieter

机构信息

Department of Cardiology, Ziekenhuis Oost-Limburg, Genk, Belgium; Biomedical Research Institute, Faculty of Medicine and Life Sciences, Hasselt University, Diepenbeek, Belgium.

Department of Cardiology, Ziekenhuis Oost-Limburg, Genk, Belgium; Doctoral School for Medicine and Life Sciences, Hasselt University, Diepenbeek, Belgium.

出版信息

JACC Heart Fail. 2018 Jun;6(6):499-502. doi: 10.1016/j.jchf.2018.02.017. Epub 2018 Apr 11.

DOI:10.1016/j.jchf.2018.02.017
PMID:29655826
Abstract
摘要

相似文献

1
Exploiting the Natriuretic Peptide Pathway to Preserve Glomerular Filtration in Heart Failure.利用利钠肽途径维持心力衰竭时的肾小球滤过功能。
JACC Heart Fail. 2018 Jun;6(6):499-502. doi: 10.1016/j.jchf.2018.02.017. Epub 2018 Apr 11.
2
How does neprilysin inhibition in heart failure work?
Eur J Heart Fail. 2019 May;21(5):606-608. doi: 10.1002/ejhf.1454. Epub 2019 Mar 18.
3
Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.血管紧张素-中性肽链内切酶抑制在射血分数保留的心力衰竭中的应用
N Engl J Med. 2020 Mar 19;382(12):1180. doi: 10.1056/NEJMc2000284.
4
Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.血管紧张素-中性肽链内切酶抑制在射血分数保留的心力衰竭中的应用
N Engl J Med. 2020 Mar 19;382(12):1180-1181. doi: 10.1056/NEJMc2000284.
5
Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.血管紧张素-中性肽链内切酶抑制在射血分数保留的心力衰竭中的应用
N Engl J Med. 2020 Mar 19;382(12):1181. doi: 10.1056/NEJMc2000284.
6
Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.血管紧张素-中性肽链内切酶抑制在射血分数保留的心力衰竭中的应用
N Engl J Med. 2020 Mar 19;382(12):1181-1182. doi: 10.1056/NEJMc2000284.
7
Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.血管紧张素-中性内肽酶抑制在射血分数保留的心力衰竭中的应用
N Engl J Med. 2020 Mar 19;382(12):1182. doi: 10.1056/NEJMc2000284.
8
Multimarker Strategy for Heart Failure Prognostication. Value of Neurohormonal Biomarkers: Neprilysin vs NT-proBNP.心力衰竭预后评估的多标志物策略。神经激素生物标志物的价值：中性肽链内切酶与N末端脑钠肽前体
Rev Esp Cardiol (Engl Ed). 2015 Dec;68(12):1075-84. doi: 10.1016/j.rec.2015.07.001. Epub 2015 Aug 19.
9
Combining angiotensin II receptor 1 antagonism and neprilysin inhibition for the treatment of heart failure.联合血管紧张素II受体1拮抗作用与中性肽链内切酶抑制作用治疗心力衰竭。
Expert Rev Clin Pharmacol. 2016 Apr;9(4):513-523. doi: 10.1586/17512433.2016.1153423. Epub 2016 Feb 29.
10
Angiotensin Receptor-Neprilysin Inhibition in Heart Failure With Reduced Ejection Fraction: A Paradigm for All?血管紧张素受体-中性肽链内切酶抑制在射血分数降低的心力衰竭中的应用：适用于所有人的范例？
JACC Heart Fail. 2016 Oct;4(10):823-825. doi: 10.1016/j.jchf.2016.07.013. Epub 2016 Sep 7.

引用本文的文献

1
Pseudo-nephropathy and hyper-excretion of urinary C-peptide: an overlooked adverse effect of an angiotensin receptor-neprilysin inhibitor (ARNI).假性肾病与尿C肽高排泄：血管紧张素受体脑啡肽酶抑制剂（ARNI）一种被忽视的不良反应
Diabetol Int. 2024 May 28;15(3):616-620. doi: 10.1007/s13340-024-00730-9. eCollection 2024 Jul.
2
Effect of sacubitril-valsartan on left ventricular remodeling in patients with acute myocardial infarction after primary percutaneous coronary intervention: a systematic review and meta-analysis.沙库巴曲缬沙坦对直接经皮冠状动脉介入治疗后急性心肌梗死患者左心室重构的影响：一项系统评价和荟萃分析
Front Pharmacol. 2024 May 28;15:1366035. doi: 10.3389/fphar.2024.1366035. eCollection 2024.
3
Effect of Sacubitril-Valsartan on Restoration and Maintenance of Sinus Rhythm in Patients With Persistent Atrial Fibrillation.
沙库巴曲缬沙坦对持续性心房颤动患者窦性心律恢复及维持的影响
Front Cardiovasc Med. 2022 May 30;9:870203. doi: 10.3389/fcvm.2022.870203. eCollection 2022.
4
Evidence-Based Medical Therapy in Patients With Heart Failure With Reduced Ejection Fraction and Chronic Kidney Disease.射血分数降低的心力衰竭合并慢性肾脏病患者的循证医学治疗。
Circulation. 2022 Mar;145(9):693-712. doi: 10.1161/CIRCULATIONAHA.121.052792. Epub 2022 Feb 28.
5
Protection of kidney function and tissue integrity by pharmacologic use of natriuretic peptides and neprilysin inhibitors.通过使用利钠肽和内肽酶抑制剂进行药理学治疗来保护肾脏功能和组织完整性。
Pflugers Arch. 2021 Apr;473(4):595-610. doi: 10.1007/s00424-021-02555-w. Epub 2021 Apr 12.
6
Role of comorbidities in heart failure prognosis Part 2: Chronic kidney disease, elevated serum uric acid.合并症在心力衰竭预后中的作用 第 2 部分：慢性肾脏病、血清尿酸升高。
Eur J Prev Cardiol. 2020 Dec;27(2_suppl):35-45. doi: 10.1177/2047487320957793.
7
Effect of sacubitril/valsartan on renal function: a systematic review and meta-analysis of randomized controlled trials.沙库巴曲缬沙坦对肾功能的影响：随机对照试验的系统评价和荟萃分析
ESC Heart Fail. 2020 Dec;7(6):3487-3496. doi: 10.1002/ehf2.13002. Epub 2020 Sep 22.
8
Angiotensin receptor-neprilysin inhibitor for the treatment of heart failure: a review of recent evidence.血管紧张素受体-脑啡肽酶抑制剂治疗心力衰竭：近期证据的综述。
Korean J Intern Med. 2020 May;35(3):498-513. doi: 10.3904/kjim.2020.105. Epub 2020 Apr 29.
9
The Effect of Sacubitril/Valsartan on Device Detected Arrhythmias and Electrical Parameters among Dilated Cardiomyopathy Patients with Reduced Ejection Fraction and Implantable Cardioverter Defibrillator.沙库巴曲缬沙坦对射血分数降低的扩张型心肌病且植入式心律转复除颤器患者器械检测到的心律失常及电参数的影响
J Clin Med. 2020 Apr 13;9(4):1111. doi: 10.3390/jcm9041111.
10
The nephroprotective effect of sacubitril/valsartan in heart failure: insights from the real-life clinical setting.沙库巴曲缬沙坦在心力衰竭中的肾脏保护作用：来自真实临床环境的见解
Intern Emerg Med. 2019 Nov;14(8):1205-1208. doi: 10.1007/s11739-019-02149-6. Epub 2019 Jul 15.